Food, Drugs, Healthcare, Life Sciences

H.R.1, signed into law by President Trump on July 4, 2025, requires that states implement work reporting requirements for adults ages 19 through 64 who are enrolled...

Passage of the budget reconciliation bill may prompt members of Congress to take on reform of pharmacy benefit managers, health savings accounts, and individual coverage health reimbursement arrangements.

The U.S. Department of Health and Human Services Office of Inspector General (OIG) has recently issued two audit reports revealing substantial improper...

On July 24, 2025, Acting Director of the USPTO, Coke Morgan Stewart, denied institution of inter partes review in IPR2025-00601 and IPR2025-00602, but referred the petition in IPR2025-00603...

In Dealmaker's Digest, read the top 10 latest developments in global transactions. We offer insights into M&A activity across industries and borders.

On August 6, the Federal Trade Commission (FTC) challenged Edwards Lifesciences Corp.'s proposed $945 million acquisition of JenaValve Technology, Inc.

In Otsuka Pharmaceutical Co. v. Sandoz, Inc., the Federal Circuit upheld the district court’s determination that the claims at issue were neither obvious nor invalid under the doctrine of obviousness-type double patenting based on a "lead compound" approach to the obviousness determinations.

After the Supreme Court decided that the personalized medicine method claims at issue in Mayo Collaborative Services v. Prometheus Laboratories, Inc. did not satisfy the patent eligibility requirements of 35 USC § 101.

GlaxoSmithKline and Genentech have settled a U.S. lawsuit related to Genentech's Cabilly II (US 6,331,415) and Cabilly III (US 7,923,221) patents.

HRSA is launching its first-ever pilot program to test 340B rebate models under strict, agency-controlled safeguards.

Bergeson & Campbell, P.C. (B&C®) affiliate The Acta Group (Acta®) is a proud sponsor of Chemical Watch's Regulatory Summit North America 2025, a four day conference providing...

Rule 23(b)(3) Damages. In an action challenging The Salvation Army's policy at its adult rehabilitation centers that prevented individuals...